跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 70 条关于
“ACTRIIA”
全部
70
临床试验
38
药物
5
机构
7
资讯
20
11个月前
AliveGen's ALG-801 Demonstrates Superior Efficacy Over Standard PAH Therapies in Preclinical Studies
去年
Laekna's LAE102 Shows Promising Safety Profile in First-in-Human Obesity Trial at ADA 2025
去年
AliveGen's ALG-801 Receives FDA Orphan Drug Designation for Pulmonary Arterial Hypertension
去年
Supercede Therapeutics Reports Promising Preclinical Data for Novel Oral Obesity Treatment Targeting ACTRII Pathway
16天前
Altria Sues FDA to Overhaul Tobacco Product Review System
去年
Astria Therapeutics Advances Navenibart for HAE with Phase 3 Trial
去年
Astria Therapeutics Expands Stock Incentive Plan to Attract Top Talent
去年
European Commission Grants Orphan Drug Designation to Astria's Navenibart for Hereditary Angioedema
去年
Astria Therapeutics Launches Phase III Trial for Novel Hereditary Angioedema Treatment
去年
Axtria Launches AI-Powered Platform to Revolutionize Clinical Study Report Generation
第 1 页,共 2 页
上一页
下一页